Lombard Medical Technologies had developed a device dubbed Aorfix stent. It has been revealed that the US Food and Drug Administration has given green signal to the company for the new product.
The aim of the firm is to increase its operations at its Scottish manufacturing plant. And probably, the approval means the company's first step on the way to enhancing operations.
Patients of multiple myeloma can now be a bit relieved since a new drug for the disease has received green signal from the US Food and Drug Administration.
The drug named Pomalyst has been manufactured by Celgene Corp. for patients whose condition worsened following treatment with other cancer drugs.
The U. S. Food & Drug Administration (FDA) has warned more than 350 medical practices that they might have received unapproved, counterfeit or unsafe medications from a Canadian supplier.
The federal food and drugs regulator said that the medications, including unapproved variants of Botox, could harm patients as they could be counterfeit or contaminated.